The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Ten recommendations to improve use of medicines in developing countries
Abstract
Inappropriate prescribing reduces the quality of medical care and leads to a waste of resources. To address these problems, a variety of educational and administrative approaches to improve prescribing have been tried. This article reviews the experiences of the last decade in order to identify which interventions have proven effective in developing countries, and suggests a range of policy options for health planners and managers. Considering the magnitude of resources that are wasted on inappropriately used drugs, many promising interventions are relatively inexpensive. Simple methods are available to monitor drug use in a standardized way and to identify inefficiencies. Intervention approaches that have proved effective in some settings are: standard treatment guidelines; essential drugs lists; pharmacy and therapeutics committees; problem-based basic professional training; and targeted in-service training of health workers. Some other interventions, such as training of drug sellers, education based on group processes and public education, need further testing, but should be supported. Several simplistic approaches have proven ineffective, such as disseminating prescribing information or clinical guidelines in written form only. Two issues that will require a long-term strategic approach are improving prescribing in the private sector and monitoring the impacts of health sector reform. Sufficient evidence is now available to persuade policy-makers that it is possible to promote rational drug use. If such effective strategies are followed, the quality of health care can be improved and drug expenditures reduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations
Grimshaw, J. M., & Russell, I. T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92244-n · Cited by 2,770
Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines
Woolf, S. H., Grol, R., Hutchinson, A., Eccles, M., & Grimshaw, J. (1999) · BMJ · doi:10.1136/bmj.318.7182.527 · Cited by 2,548
Bero, L. A., Grilli, R., Grimshaw, J. M., Harvey, E., Oxman, A. D., & Thomson, M. A. (1998) · BMJ · doi:10.1136/bmj.317.7156.465 · Cited by 2,396
Davis, D., O'Brien, M. A. T., Freemantle, N., Wolf, F. M., Mazmanian, P., & Taylor-Vaisey, A. (1999) · JAMA · doi:10.1001/jama.282.9.867 · Cited by 2,364
Davis, D. A. (1995) · JAMA · doi:10.1001/jama.1995.03530090032018 · Cited by 1,763
Hoffman, L. R. (1965) · Advances in Experimental Social Psychology · doi:10.1016/s0065-2601(08)60104-5 · Cited by 455
How to investigate drug use in health facilities. Selected drug use indicators
Ghei, P. (1995) · Health Policy · doi:10.1016/0168-8510(95)90068-3 · Cited by 366
Mittman, B. S., Tonesk, X., & Jacobson, P. D. (1992) · QRB - Quality Review Bulletin · doi:10.1016/s0097-5990(16)30567-x · Cited by 347
Field tests for rational drug use in twelve developing countries
Hogerzeil, H. V., Bimo, Ross-Degnan, D., Laing, R. O., Ofori-Adjei, D., Santoso, B., Azad Chowdhury, A. K., Das, A. M., Kafle, K. K., Mabadeje, A. F. B., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92760-q · Cited by 328
Self-citationA National Survey of the Arrangements Managed-Care Plans Make with Physicians
Gold, M. R., Hurley, R., Lake, T., Ensor, T., & Berenson, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332505 · Cited by 271
Freemantle, N., & Bloor, K. E. (1996) · BMJ · doi:10.1136/bmj.312.7044.1469 · Cited by 126
The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies
ROSS-DEGNAN, D., SOUMERAI, S. B., GOEL, P. K., BATES, J., MAKHULO, J., DONDI, N., SUTOTO, ADI, D., FERRAZ-TABOR, L., & HOGAN, R. (1996) · Health Policy and Planning · doi:10.1093/heapol/11.3.308 · Cited by 123
Self-citationEffect of training on the clinical management of malaria by medical assistants in Ghana
Ofori‐Adjei, D., & Arhinful, D. K. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00389-4 · Cited by 116
Small group intervention vs formal seminar for improving appropriate drug use
Santoso, B. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00390-8 · Cited by 106
Computer-Based Drug-Utilization Review — Risk, Benefit, or Boondoggle?
Soumerai, S. B., & Lipton, H. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322411 · Cited by 103
Hadiyono, J. E. P., Suryawati, S., Danu, S. S., Sunartono, & Santoso, B. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00391-6 · Cited by 94
Improving primary health care through systematic supervision: a controlled field trial
LOEVINSOHN, B. P., GUERRERO, E. T., & GREGORIO, S. P. (1995) · Health Policy and Planning · doi:10.1093/heapol/10.2.144 · Cited by 84
Rational Drug Use: An Unsolved Problem
Laing, R. O. (1990) · Tropical Doctor · doi:10.1177/004947559002000303 · Cited by 74
Self-citationImproving the use of pharmaceuticals through patient and community level interventions
Homedes, N., & Ugalde, A. (2001) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00131-3 · Cited by 66
rrez, G. G., Guiscafr, H. C., Bronfman, M., Walsh, J., nez, H. M. ́., & oz, O. M. (1994) · Medical Care · doi:10.1097/00005650-199405000-00003 · Cited by 64
Improving drug use through continuing education: A randomized controlled trial in Zambia
Bexell, A., Lwando, E., von Hofsten, B., Tembo, S., Eriksson, B., & Diwan, V. K. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00059-3 · Cited by 64
Quick, J. D., Laing, R. O., & Ross‐Degnan, D. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90114-o · Cited by 60
Self-citationDrug and Therapeutics Committees in Australia: expected and actual performance
Weekes, L., & Brooks, C. (1996) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1996.tb00048.x · Cited by 48
Antibiotic formulary selection
Crowe, H. M., & Quintiliani, R. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30050-5 · Cited by 28
Indicators for Monitoring National Drug Policies
Brudon, P., Rainhorn, J.-D., & Reich, M. R. (1999) · Cited by 23
The essential drugs programme in Zimbabwe: new approaches to training
Laing, R. O., & RUREDZO, R. (1989) · Health Policy and Planning · doi:10.1093/heapol/4.3.229 · Cited by 22
Self-citationMyths and realities about the decentralization of health systems
Kolehmainen‐Aitken, R. (1999) · Cited by 16
Guiscafré, H., Martı́nez, H., Reyes, H., Pérez‐Cuevas, R., Castro, R., Muñoz, O., & Gutiérrez, G. (1995) · PubMed · Cited by 15
Cited by
How can we achieve and maintain high-quality performance of health workers in low-resource settings?
Rowe, A. K., de Savigny, D., Lanata, C. F., & Victora, C. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67028-6 · Cited by 1,045
Access to medicines from a health system perspective
Bigdeli, M., Jacobs, B., Tomson, G., Laing, R., Ghaffar, A., Dujardin, B., & Van Damme, W. (2013) · Health Policy and Planning · doi:10.1093/heapol/czs108 · Cited by 348
Self-citationDesalegn, A. A. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-170 · Cited by 332
Antimicrobial resistance in developing countries. Part II: strategies for containment
Okeke, I. N., Klugman, K. P., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Laxminarayan, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70217-6 · Cited by 290
Li, Y., Xu, J., Wang, F., Wang, B., Liu, L., Hou, W., Fan, H., Tong, Y., Zhang, J., & Lu, Z. (2012) · Health Affairs · doi:10.1377/hlthaff.2010.0965 · Cited by 253
Metadata
- Authors
- Laing, R.
- Venue
- Health Policy and Planning
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-03-01
- Volume
- 16
- Issue
- 1
- Pages
- 13-20
- ISSN
- 0268-1080 (ISSN-L)
- 1460-2237
- OpenAlex
- W2140997499
- Cited by
- 319
- References
- 28
- FWCI
- 30.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.